ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2023
[Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review].
Xue Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.